NCT02195635View on ClinicalTrials.gov

Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2014

Conditions
Drug Interactions
Interventions
DRUG

Telotristat etiprate

500 mg telotristat etiprate

DRUG

Octreotide acetate

200 µg octreotide acetate three times daily

Trial Locations (1)

32117

Lexicon Investigational Site, Daytona Beach

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY